Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Protocol for Immunology Specimen Collection From Cancer Patients, Patients With Hematologic Diagnoses, and Healthy Normal Controls
Sponsor: National Cancer Institute (NCI)
Listed as NCT03207854, this observational or N/A phase trial focuses on Healthy Subject and Hematologic and Lymphocytic Disorder and remains actively recruiting participants. Sponsored by National Cancer Institute (NCI), it has been updated 16 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
16 versions recorded-
Aug 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Recruiting
-
Sep 2023 — Jun 2024 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Nov 2020 [monthly]
Recruiting
-
Oct 2018 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .